R-Pharm
R-Pharm, officially known as R-Pharm Group, is a prominent player in the pharmaceutical industry, headquartered in Russia. Established in 2001, the company has made significant strides in the development, production, and distribution of innovative medicines, particularly in oncology, neurology, and infectious diseases. With a strong operational presence across Europe and Asia, R-Pharm is recognised for its commitment to high-quality pharmaceuticals and advanced biotechnological solutions. The company’s core offerings include proprietary drugs and biosimilars, distinguished by their efficacy and safety profiles. R-Pharm has achieved notable milestones, including partnerships with leading global pharmaceutical firms, positioning itself as a key contributor to the healthcare landscape. Its dedication to research and development underscores its reputation as a forward-thinking entity in the competitive pharmaceutical market.
DitchCarbon Score
How does R-Pharm's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
R-Pharm's score of 0 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
R-Pharm's reported carbon emissions
R-Pharm, headquartered in Russia (RU), currently does not have publicly available data on its carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This lack of data suggests that R-Pharm may still be in the early stages of formalising its climate commitments or reporting on its carbon footprint. In the context of the pharmaceutical industry, companies are increasingly expected to adopt transparent climate strategies and set measurable targets to reduce their greenhouse gas emissions across all scopes. Without specific emissions data or reduction initiatives, it is challenging to assess R-Pharm's current environmental impact or future commitments.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
R-Pharm is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
